What is the ROCE (Return on Capital Employed) of IVERIC bio this year?
The ROCE of IVERIC bio is -0.36 undefined this year.
IVERIC bio ROCE 2024
IVERIC bio ROCE
-0.36
Ticker
ISEE
ISIN
US46583P1021
WKN
A2PHLF
In 2024, IVERIC bio's return on capital employed (ROCE) was -0.36, a 11.59% increase from the -0.32 ROCE in the previous year.
IVERIC bio Aktienanalyse
What does IVERIC bio do?
Iveric Bio Inc is a leading biopharmaceutical company specializing in the discovery and development of therapy options for eye diseases. The company was originally founded in 1989 as Ophthotech Corp. and is headquartered in New York City. Iveric Bio Inc aims to develop innovative treatments for eye diseases that can improve the lives of millions of people. The eye diseases that Iveric Bio Inc is fighting range from retinal diseases to degenerative eye diseases. Iveric Bio Inc has a strong business model, focusing on innovation to develop new treatment methods. The company invests in research and development to create a solid pipeline of new therapies, while also closely collaborating with the medical community to ensure that the therapies meet the needs of patients and doctors. Iveric Bio Inc's therapy options are focused on treating eye diseases such as age-related macular degeneration, diabetic retinopathy, and other retinal diseases. Iveric Bio Inc also focuses on preserving vision and improving the quality of life for people with glaucoma and other eye diseases. Iveric Bio Inc's portfolio currently includes two main products: Zimura and GATHER1. Zimura is a potentially groundbreaking medication developed for the treatment of dry age-related macular degeneration (AMD). It is currently being studied in late-stage clinical trials and could play an important role in the future of AMD treatment. GATHER1, the other main product of Iveric Bio Inc, is a clinical drug candidate developed for the treatment of geographic atrophy (GA). GA is an advanced form of dry AMD associated with the destruction of cells in the retina and a loss of vision. GATHER1 has been deemed promising in Phase II trials and is currently being tested in Phase III trials. Overall, Iveric Bio Inc has an excellent track record in the development of therapy options for eye diseases. The company has a wide range of treatment possibilities in the pipeline aimed at meeting the need for effective therapies for various eye diseases. Additionally, Iveric Bio Inc works closely with the medical community and other biopharmaceutical companies to share the latest research findings and advance the treatment of eye diseases. Overall, Iveric Bio Inc is an emerging biopharmaceutical company with a strong focus on research and development. The company has a strong business model and a robust pipeline of therapy options aimed at improving eye health and the quality of life for millions of people. IVERIC bio ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling IVERIC bio's Return on Capital Employed (ROCE)
IVERIC bio's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing IVERIC bio's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
IVERIC bio's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in IVERIC bio’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about IVERIC bio stock
How has the ROCE (Return on Capital Employed) of IVERIC bio developed compared to the previous year?
The ROCE of IVERIC bio has increased by 11.59% increased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of IVERIC bio?
A high Return on Capital Employed (ROCE) indicates that IVERIC bio has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of IVERIC bio?
A low ROCE (Return on Capital Employed) can indicate that IVERIC bio has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from IVERIC bio impact the company?
An increase in the ROCE of IVERIC bio can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of IVERIC bio affect the company?
A decrease in ROCE of IVERIC bio can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of IVERIC bio?
Some factors that can affect IVERIC bio's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of IVERIC bio so important for investors?
The ROCE of IVERIC bio is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can IVERIC bio take to improve the ROCE?
To improve the ROCE, IVERIC bio can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does IVERIC bio pay?
Over the past 12 months, IVERIC bio paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, IVERIC bio is expected to pay a dividend of 0 USD.
What is the dividend yield of IVERIC bio?
The current dividend yield of IVERIC bio is .
When does IVERIC bio pay dividends?
IVERIC bio pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of IVERIC bio?
IVERIC bio paid dividends every year for the past 0 years.
What is the dividend of IVERIC bio?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is IVERIC bio located?
IVERIC bio is assigned to the 'Health' sector.
Wann musste ich die Aktien von IVERIC bio kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of IVERIC bio from 11/8/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/8/2024.
When did IVERIC bio pay the last dividend?
The last dividend was paid out on 11/8/2024.
What was the dividend of IVERIC bio in the year 2023?
In the year 2023, IVERIC bio distributed 0 USD as dividends.
In which currency does IVERIC bio pay out the dividend?
The dividends of IVERIC bio are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von IVERIC bio
Our stock analysis for IVERIC bio Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of IVERIC bio Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
